As of Oct 27
| -0.10 / -1.16%|
The 6 analysts offering 12-month price forecasts for Pacific Biosciences of California Inc have a median target of 12.00, with a high estimate of 18.00 and a low estimate of 11.00. The median estimate represents a +41.18% increase from the last price of 8.50.
The current consensus among 7 polled investment analysts is to Buy stock in Pacific Biosciences of California Inc. This rating has held steady since October, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.